BioSpace News Archive

Press Releases

Lexeo Therapeutics Announces Proposed Offering of Common Stock and Pre-Funded Warrants

October 17, 2025
·
5 min read
Press Releases

Disc Medicine Announces Receipt of FDA Commissioner’s National Priority Voucher (CNPV) for Bitopertin in Erythropoietic Protoporphyria (EPP)

October 17, 2025
·
6 min read
Press Releases

AVITA Medical Announces CEO Transition

October 17, 2025
·
5 min read
Press Releases

Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement

October 17, 2025
·
5 min read
Press Releases

Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering

October 17, 2025
·
4 min read
Press Releases

FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States

October 17, 2025
·
18 min read
Press Releases

AB Science announces the successful completion of a EUR 2.8 million private placement

October 17, 2025
·
11 min read
Press Releases

AKYNZEO® demonstrates superior prevention of chemotherapy-induced nausea and vomiting compared to the standard of care in patients receiving moderately emetogenic chemotherapy with additional predictive factors

October 17, 2025
·
5 min read
Press Releases

TOLREMO therapeutics Completes First In Human Dose Escalation for TT125-802 and Presents Solid Tumor Monotherapy Results at ESMO 2025

October 17, 2025
·
5 min read
Press Releases

ITM to Announce Phase 3 COMPETE Trial Post Hoc Subgroup Analyses and Host Satellite Symposium at NANETS 2025

October 17, 2025
·
3 min read